Skip to main content
Top
Published in: Cancer Causes & Control 3/2013

01-03-2013 | Original paper

Clustering of place of birth for women with breast cancer: differences by tumor characteristics

Authors: Daikwon Han, Jing Nie, Matthew R. Bonner, Christine Ambrosone, Catalin Marian, Peter Shields, Maurizio Trevisan, Stephen B. Edge, Jo L. Freudenheim

Published in: Cancer Causes & Control | Issue 3/2013

Login to get access

Abstract

Purpose

There is increasing evidence that exposures in early life affect breast cancer risk, and that breast cancer etiology differs by tumor subtype. If environmental exposures in early life contribute to risk, it is expected that there would be clustering of women with breast cancer by their place of birth, and that clustering might differ by subtype. We examined spatial associations between place of birth and breast cancer by subtype, using hormone receptor status and molecular profiles of breast tumors.

Methods

Data were drawn from the Western New York Exposures and Breast Cancer study, a population-based case–control study of incident, pathologically confirmed breast cancer (1996–2001) in Erie and Niagara Counties. Included were women born in the study area (579 cases and 931 controls). Clustering of breast cancer subgroups relative to controls was examined by the k-function method in groups stratified by estrogen receptor (ER), progesterone receptor (PR), and HER2 status, and by DNA methylation status and p53 mutation status, and the k-function difference was used to compare relative spatial aggregation and spatial range of the difference between case subgroups and controls.

Results

We found a tendency to cluster among ER positive, PR positive, and HER2 negative cases (i.e., luminal A subtype), especially among premenopausal women, but not among the other groups defined by hormonal receptor status, or by either methylation or p53 mutation status.

Conclusions

While our findings cannot rule out clustering of cases by birth place because of shared behaviors related to residence location, they also suggest that early life environmental exposures may affect subsequent breast cancer risk, and that premenopausal breast tumors of the luminal A subtype may be more affected by these early life exposures than other subtypes.
Literature
1.
go back to reference Lacey JV Jr, Devesa SS, Brinton LA (2002) Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 39:82–88PubMedCrossRef Lacey JV Jr, Devesa SS, Brinton LA (2002) Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 39:82–88PubMedCrossRef
2.
go back to reference Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13:1558–1568PubMed Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13:1558–1568PubMed
3.
go back to reference Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289:1421–1424PubMedCrossRef Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289:1421–1424PubMedCrossRef
4.
go back to reference Perou CM, Sorlie T, Eisen MB, Van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A et al (2000) Molecular portraits of human breast tumors. Nature 406:747–752PubMedCrossRef Perou CM, Sorlie T, Eisen MB, Van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A et al (2000) Molecular portraits of human breast tumors. Nature 406:747–752PubMedCrossRef
5.
go back to reference Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502PubMedCrossRef Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502PubMedCrossRef
6.
go back to reference Gregorio DI, Kulldorff M, Barry L, Samociuk H (2002) Geographic differences in invasive and in situ breast cancer incidence according to precise geographic coordinates, Connecticut, 1991-95. Int J Cancer 100:194–198PubMedCrossRef Gregorio DI, Kulldorff M, Barry L, Samociuk H (2002) Geographic differences in invasive and in situ breast cancer incidence according to precise geographic coordinates, Connecticut, 1991-95. Int J Cancer 100:194–198PubMedCrossRef
7.
go back to reference Sheehan TJ, DeChello LM (2005) A space-time analysis of the proportion of late stage breast cancer in Massachusetts, 1988 to 1997. Int J Health Geogr 4:15PubMedCrossRef Sheehan TJ, DeChello LM (2005) A space-time analysis of the proportion of late stage breast cancer in Massachusetts, 1988 to 1997. Int J Health Geogr 4:15PubMedCrossRef
8.
go back to reference Benz CC, Clarke CA, Moore DH 2nd (2003) Geographic excess of estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 12:1523–1527PubMed Benz CC, Clarke CA, Moore DH 2nd (2003) Geographic excess of estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 12:1523–1527PubMed
9.
go back to reference Han D, Rogerson PA, Nie J, Bonner MR, Vena JE, Muti P, Trevisan M, Edge SB, Freudenheim JL (2004) Geographic clustering of residence in early life and subsequent risk of breast cancer (United States). Cancer Causes Control 15:921–929PubMedCrossRef Han D, Rogerson PA, Nie J, Bonner MR, Vena JE, Muti P, Trevisan M, Edge SB, Freudenheim JL (2004) Geographic clustering of residence in early life and subsequent risk of breast cancer (United States). Cancer Causes Control 15:921–929PubMedCrossRef
10.
go back to reference Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathol 11:155–168 Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathol 11:155–168
11.
go back to reference Tennis M, Krishnan S, Bonner M, Ambrosone CB, Vena JE, Moysich K, Swede H, McCann S, Hall P, Shields PG, Freudenheim JL (2006) p53 Mutation analysis in breast tumors by a DNA microarray method. Cancer Epidemiol Biomarkers Prev 15:80–85PubMedCrossRef Tennis M, Krishnan S, Bonner M, Ambrosone CB, Vena JE, Moysich K, Swede H, McCann S, Hall P, Shields PG, Freudenheim JL (2006) p53 Mutation analysis in breast tumors by a DNA microarray method. Cancer Epidemiol Biomarkers Prev 15:80–85PubMedCrossRef
13.
go back to reference Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103:250–263PubMedCrossRef Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103:250–263PubMedCrossRef
14.
go back to reference Xue F, Michels KB (2007) Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol 8:1088–1100PubMedCrossRef Xue F, Michels KB (2007) Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol 8:1088–1100PubMedCrossRef
15.
go back to reference Silva IdS, Stavola BD, McCormack V, Collaborative Group on Pre-Natal Risk Factors and Subsequent Risk of Breast Cancer (2008) Birth size and breast cancer risk: re-analysis of individual participant data from 32 Studies. PLoS Med 5:e193CrossRef Silva IdS, Stavola BD, McCormack V, Collaborative Group on Pre-Natal Risk Factors and Subsequent Risk of Breast Cancer (2008) Birth size and breast cancer risk: re-analysis of individual participant data from 32 Studies. PLoS Med 5:e193CrossRef
16.
go back to reference Park SK, Kang D, McGlynn KA, Garcia-Closas M, Kim Y, Yoo KY, Brinton LA (2008) Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res 10(1):R8PubMedCrossRef Park SK, Kang D, McGlynn KA, Garcia-Closas M, Kim Y, Yoo KY, Brinton LA (2008) Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res 10(1):R8PubMedCrossRef
17.
go back to reference Naccarato AG, Viacava P, Vignati S, Fanelli G, Bonadio AG, Montruccoli G, Bevilacqua G (2000) Bio-morphological events in the development of the human female mammary gland from fetal age to puberty. Virchows Arch 436:431–438PubMedCrossRef Naccarato AG, Viacava P, Vignati S, Fanelli G, Bonadio AG, Montruccoli G, Bevilacqua G (2000) Bio-morphological events in the development of the human female mammary gland from fetal age to puberty. Virchows Arch 436:431–438PubMedCrossRef
18.
go back to reference Michels KB, Xue F, Terry KL, Willett WC (2006) Longitudinal study of birthweight and the incidence of breast cancer in adulthood. Carcinogenesis 27:2464–2468PubMedCrossRef Michels KB, Xue F, Terry KL, Willett WC (2006) Longitudinal study of birthweight and the incidence of breast cancer in adulthood. Carcinogenesis 27:2464–2468PubMedCrossRef
19.
go back to reference Hurley S, Goldberg D, Von Behren J, Quach T, Layefsky M, Reynolds P (2011) Birth size and breast cancer risk among young California-born women. Cancer Causes Control 22:1461–1470PubMedCrossRef Hurley S, Goldberg D, Von Behren J, Quach T, Layefsky M, Reynolds P (2011) Birth size and breast cancer risk among young California-born women. Cancer Causes Control 22:1461–1470PubMedCrossRef
20.
go back to reference Ahlgren M, Sørensen T, Wohlfahrt J, Haflidadóttir A, Holst C, Melbye M (2003) Birth weight and risk of breast cancer in a cohort of 106,504 women. Int J Cancer 107:997–1000PubMedCrossRef Ahlgren M, Sørensen T, Wohlfahrt J, Haflidadóttir A, Holst C, Melbye M (2003) Birth weight and risk of breast cancer in a cohort of 106,504 women. Int J Cancer 107:997–1000PubMedCrossRef
21.
go back to reference Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151:703–714PubMedCrossRef Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151:703–714PubMedCrossRef
22.
go back to reference Troisi R, Hatch EE, Titus-Ernstoff L, Hyer M, Palmer JR, Robboy SJ, Strohsnitter WC, Kaufman R, Herbst AL, Hoover RN (2007) Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer 121:356–360PubMedCrossRef Troisi R, Hatch EE, Titus-Ernstoff L, Hyer M, Palmer JR, Robboy SJ, Strohsnitter WC, Kaufman R, Herbst AL, Hoover RN (2007) Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer 121:356–360PubMedCrossRef
23.
go back to reference Palmer JR, Hatch EE, Rosenberg CL, Hartge P, Kaufman RH, Titus-Ernstoff L, Noller KL, Herbst AL, Rao RS, Troisi R, Colton T, Hoover RN (2002) Risk of breast cancer in women exposed to diethylstilbestrol in utero: preliminary results (United States). Cancer Causes Control 13:753–758PubMedCrossRef Palmer JR, Hatch EE, Rosenberg CL, Hartge P, Kaufman RH, Titus-Ernstoff L, Noller KL, Herbst AL, Rao RS, Troisi R, Colton T, Hoover RN (2002) Risk of breast cancer in women exposed to diethylstilbestrol in utero: preliminary results (United States). Cancer Causes Control 13:753–758PubMedCrossRef
24.
go back to reference Hoover RN, Hyer M, Pfeiffer RM, Adam E, Bond B, Cheville AL, Colton T, Hartge P, Hatch EE, Herbst AL, Karlan BY, Kaufman R et al (2011) Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 365:1304–1314PubMedCrossRef Hoover RN, Hyer M, Pfeiffer RM, Adam E, Bond B, Cheville AL, Colton T, Hartge P, Hatch EE, Herbst AL, Karlan BY, Kaufman R et al (2011) Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 365:1304–1314PubMedCrossRef
25.
go back to reference Palmer JR, Wise LA, Hatch EE, Troisi R, Titus-Ernstoff L, Strohsnitter W, Kaufman R, Herbst AL, Noller KL, Hyer M, Hoover RN (2006) Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15:1509–1514PubMedCrossRef Palmer JR, Wise LA, Hatch EE, Troisi R, Titus-Ernstoff L, Strohsnitter W, Kaufman R, Herbst AL, Noller KL, Hyer M, Hoover RN (2006) Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15:1509–1514PubMedCrossRef
26.
go back to reference Troisi R, Potischman N, Hoover RN (2007) Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary. Cancer Epidemiol Biomarkers Prev 16:1700–1712PubMedCrossRef Troisi R, Potischman N, Hoover RN (2007) Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary. Cancer Epidemiol Biomarkers Prev 16:1700–1712PubMedCrossRef
27.
go back to reference Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819–1826PubMedCrossRef Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819–1826PubMedCrossRef
28.
go back to reference Kolonel L, Wilkens L (2006) Migrant Studies. In: Schottenfeld D, Fraumeni J (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 189–201CrossRef Kolonel L, Wilkens L (2006) Migrant Studies. In: Schottenfeld D, Fraumeni J (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 189–201CrossRef
29.
go back to reference Falk RT, Fears TR, Hoover RN, Pike MC, Wu AH, Nomura AM, Kolonel LN, West DW, Ziegler RG (2002) Does place of birth influence endogenous hormone levels in Asian-American women? Br J Cancer 87:54–60PubMedCrossRef Falk RT, Fears TR, Hoover RN, Pike MC, Wu AH, Nomura AM, Kolonel LN, West DW, Ziegler RG (2002) Does place of birth influence endogenous hormone levels in Asian-American women? Br J Cancer 87:54–60PubMedCrossRef
30.
go back to reference Bonner MR, Han D, Nie J, Rogerson PA, Vena JE, Muti P, Trevisan M, Edge SB, Freudenheim JL (2005) Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev 14:53–60PubMed Bonner MR, Han D, Nie J, Rogerson PA, Vena JE, Muti P, Trevisan M, Edge SB, Freudenheim JL (2005) Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev 14:53–60PubMed
31.
go back to reference Crouse DL, Goldberg MS, Ross NA, Chen H, Labrèche F (2010) Postmenopausal breast cancer is associated with exposure to traffic-related air pollution in Montreal, Canada: a case-control study. Environ Health Perspect 118:1578–1583PubMedCrossRef Crouse DL, Goldberg MS, Ross NA, Chen H, Labrèche F (2010) Postmenopausal breast cancer is associated with exposure to traffic-related air pollution in Montreal, Canada: a case-control study. Environ Health Perspect 118:1578–1583PubMedCrossRef
32.
go back to reference Nie J, Beyea J, Bonner MR, Han D, Vena J, Rogerson P, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL (2007) Exposure to traffic emissions throughout life and risk of breast cancer: the Western New York Exposures and Breast Cancer (WEB) study. Cancer Causes Control 18:947–955PubMedCrossRef Nie J, Beyea J, Bonner MR, Han D, Vena J, Rogerson P, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL (2007) Exposure to traffic emissions throughout life and risk of breast cancer: the Western New York Exposures and Breast Cancer (WEB) study. Cancer Causes Control 18:947–955PubMedCrossRef
33.
go back to reference Petralia SA, Vena JE, Freudenheim JL, Dosemeci M, Michalek A, Goldberg MS, Brasure J, Graham S (1999) Risk of premenopausal breast cancer in association with occupational exposure to polycyclic aromatic hydrocarbons and benzene. Scand J Work Environ Health 25:215–221PubMedCrossRef Petralia SA, Vena JE, Freudenheim JL, Dosemeci M, Michalek A, Goldberg MS, Brasure J, Graham S (1999) Risk of premenopausal breast cancer in association with occupational exposure to polycyclic aromatic hydrocarbons and benzene. Scand J Work Environ Health 25:215–221PubMedCrossRef
34.
go back to reference Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP, Rudel RA (2007) Environmental pollutants and breast cancer. Cancer 109:2667–2711PubMedCrossRef Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP, Rudel RA (2007) Environmental pollutants and breast cancer. Cancer 109:2667–2711PubMedCrossRef
35.
go back to reference Safe SH (1997) Is there an association between exposure to environmental estrogens and breast cancer? Environ Health Perspect 105(Suppl 3):675–678PubMedCrossRef Safe SH (1997) Is there an association between exposure to environmental estrogens and breast cancer? Environ Health Perspect 105(Suppl 3):675–678PubMedCrossRef
Metadata
Title
Clustering of place of birth for women with breast cancer: differences by tumor characteristics
Authors
Daikwon Han
Jing Nie
Matthew R. Bonner
Christine Ambrosone
Catalin Marian
Peter Shields
Maurizio Trevisan
Stephen B. Edge
Jo L. Freudenheim
Publication date
01-03-2013
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 3/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-9997-7

Other articles of this Issue 3/2013

Cancer Causes & Control 3/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine